Finzati - Logo
PCVX logo

Vaxcyte, Inc.

PCVXBiotechnology
$0.00
0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$8.50B
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.09Healthy liquidity · 7.91Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$8.50B
52W Range29.08 - 65.00
Beta1.22
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.09
Current Ratio7.91
Quick Ratio7.91
Target$89.00

Investment DNA

How strong this company looks for long-term investors

46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score
Manageable debt level · 0.09Healthy liquidity · 7.91Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$89.00
Mean
$89.00
Median
$89.00
High
$89.00

Company Overview

IPO: 6/12/2020
Industry: Biotechnology
P/B i: 2.34
Debt / Equity i: 0.09
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.09
Current Ratio: 7.91
Quick Ratio: 7.91
Status: Good

Insider Transactions

Recent executive and insider activity

Dhaliwal Harpreet S.
Transaction: 08/05/2026
SELL
Change
-17,000
Price
$24.79
Filing
08/05/2026
Type
SELL
Dhaliwal Harpreet S.
Transaction: 08/05/2026
SELL
Change
-17,000
Price
$55.00
Filing
08/05/2026
Type
SELL
GUGGENHIME ANDREW
Transaction: 08/03/2026
SELL
Change
-3,044
Price
$54.18
Filing
08/05/2026
Type
SELL